|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vargas AJ and Thompson PA: Diet and
nutrient factors in colorectal cancer risk. Nutr Clin Pract.
27:613–623. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meyerhardt JA and Mayer RJ: Systemic
therapy for colorectal cancer. N Engl J Med. 352:476–487. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Juez I, Rubio C and Figueras J:
Multidisciplinary approach of colorectal liver metastases. Clin
Transl Oncol. 13:721–727. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stahlhut C and Slack FJ: MicroRNAs and the
cancer phenotype: Profiling, signatures and clinical implications.
Genome Med. 5:1112013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bueno MJ, Pérez de Castro I and Malumbres
M: Control of cell proliferation pathways by microRNAs. Cell Cycle.
7:3143–3148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Babashah S and Soleimani M: The oncogenic
and tumour suppressive roles of microRNAs in cancer and apoptosis.
Eur J Cancer. 47:1127–1137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu Q, Zhang J, Xu X, Qian F, Feng K and Ma
J: miR-203 is a predictive biomarker for colorectal cancer and its
expression is associated with BIRC5. Tumour Biol. Oct 6–2016.(Epub
ahead of print). View Article : Google Scholar :
|
|
15
|
Shi C and Zhang Z: MicroRNA-362 is
downregulated in cervical cancer and inhibits cell proliferation,
migration and invasion by directly targeting SIX1. Oncol Rep.
37:501–509. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei W, Yang Y, Cai J, Cui K, Li RX, Wang
H, Shang X and Wei D: MiR-30a-5p suppresses tumor metastasis of
human colorectal cancer by targeting ITGB3. Cell Physiol Biochem.
39:1165–1176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng YB, Xiao K, Xiao GC, Tong SL, Ding
Y, Wang QS, Li SB and Hao ZN: MicroRNA-103 promotes tumor growth
and metastasis in colorectal cancer by directly targeting LATS2.
Oncol Lett. 12:2194–2200. 2016.PubMed/NCBI
|
|
18
|
Zhou C, Tan DM, Chen L, Xu XY, Sun CC,
Zong LJ, Han S and Zhang YZ: Effect of miR-212 targeting TCF7L2 on
the proliferation and metastasis of cervical cancer. Eur Rev Med
Pharmacol Sci. 21:219–226. 2017.PubMed/NCBI
|
|
19
|
Zhu L, Huang F, Deng G, Nie W, Huang W, Xu
H, Zheng S, Yi Z and Wan T: MicroRNA-212 targets FOXA1 and
suppresses the proliferation and invasion of intrahepatic
cholangiocarcinoma cells. Exp Ther Med. 12:3790–3796. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q,
Yang W, Yao Y, Liu Q and Tu K: MicroRNA-212 suppresses tumor growth
of human hepatocellular carcinoma by targeting FOXA1. Oncotarget.
6:13216–13228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang G, Yang X, Li C, Cao X, Luo X and Hu
J: PIK3R3 induces epithelial-to-mesenchymal transition and promotes
metastasis in colorectal cancer. Mol Cancer Ther. 13:1837–1847.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and −5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao G, Dong W, Meng X, Liu H, Liao H and
Liu S: MiR-511 inhibits growth and metastasis of human
hepatocellular carcinoma cells by targeting PIK3R3. Tumour Biol.
36:4453–4459. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu K, Li X, Cao Y, Ge Y, Wang J and Shi
B: MiR-132 inhibits cell proliferation, invasion and migration of
hepatocellular carcinoma by targeting PIK3R3. Int J Oncol.
47:1585–1593. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Du L, Yang Y, Wang C, Liu H, Wang L,
Zhang X, Li W, Zheng G and Dong Z: MiR-429 is an independent
prognostic factor in colorectal cancer and exerts its
anti-apoptotic function by targeting SOX2. Cancer Lett. 329:84–90.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng GX, Qu AL, Yang YM, Zhang X, Zhang
SC and Wang CX: miR-422a is an independent prognostic factor and
functions as a potential tumor suppressor in colorectal cancer.
World J Gastroenterol. 22:5589–5597. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li P, Xue WJ, Feng Y and Mao QS:
MicroRNA-205 functions as a tumor suppressor in colorectal cancer
by targeting cAMP responsive element binding protein 1 (CREB1). Am
J Transl Res. 7:2053–2059. 2015.PubMed/NCBI
|
|
29
|
Li D, Li Z, Xiong J, Gong B, Zhang G, Cao
C, Jie Z, Liu Y, Cao Y, Yan Y, et al: MicroRNA-212 functions as an
epigenetic-silenced tumor suppressor involving in tumor metastasis
and invasion of gastric cancer through down-regulating PXN
expression. Am J Cancer Res. 5:2980–2997. 2015.PubMed/NCBI
|
|
30
|
Meng X, Wu J, Pan C, Wang H, Ying X, Zhou
Y, Yu H, Zuo Y, Pan Z, Liu RY and Huang W: Genetic and epigenetic
down-regulation of microRNA-212 promotes colorectal tumor
metastasis via dysregulation of MnSOD. Gastroenterology.
145:426–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Damavandi Z, Torkashvand S, Vasei M,
Soltani BM, Tavallaei M and Mowla SJ: Aberrant expression of breast
development-related MicroRNAs, miR-22, miR-132, and miR-212, in
breast tumor tissues. J Breast Cancer. 19:148–155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wei LQ, Liang HT, Qin DC, Jin HF, Zhao Y
and She MC: MiR-212 exerts suppressive effect on SKOV3 ovarian
cancer cells through targeting HBEGF. Tumour Biol. 35:12427–12434.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu H, Li C, Shen C, Yin F, Wang K, Liu Y,
Zheng B, Zhang W, Hou X, Chen X, et al: MiR-212-3p inhibits
glioblastoma cell proliferation by targeting SGK3. J Neurooncol.
122:431–439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M,
Quan ZX and Chen J: MicroRNA-212 inhibits osteosarcoma cells
proliferation and invasion by down-regulation of Sox4. Cell Physiol
Biochem. 34:2180–2188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu Z, Zhou L, Ding G and Cao L:
Overexpressions of miR-212 are associated with poor prognosis of
patients with pancreatic ductal adenocarcinoma. Cancer Biomark.
18:35–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun SM, Rockova V, Bullinger L, Dijkstra
MK, Döhner H, Löwenberg B and Jongen-Lavrencic M: The prognostic
relevance of miR-212 expression with survival in cytogenetically
and molecularly heterogeneous AML. Leukemia. 27:100–106. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao JL, Zhang L, Guo X, Wang JH, Zhou W,
Liu M, Li X and Tang H: miR-212/132 downregulates SMAD2 expression
to suppress the G1/S phase transition of the cell cycle and the
epithelial to mesenchymal transition in cervical cancer cells.
IUBMB Life. 67:380–394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hanieh H: Aryl hydrocarbon
receptor-microRNA-212/132 axis in human breast cancer suppresses
metastasis by targeting SOX4. Mol Cancer. 14:1722015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiping Z, Ming F, Lixiang W, Xiuming L,
Yuqun S, Han Y, Zhifang L, Yundong S, Shili L, Chunyan C and Jihui
J: MicroRNA-212 inhibits proliferation of gastric cancer by
directly repressing retinoblastoma binding protein 2. J Cell
Biochem. 114:2666–2672. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ma C, Nong K, Wu B, Dong B, Bai Y, Zhu H,
Wang W, Huang X, Yuan Z and Ai K: miR-212 promotes pancreatic
cancer cell growth and invasion by targeting the hedgehog signaling
pathway receptor patched-1. J Exp Clin Cancer Res. 33:542014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jackson RJ and Standart N: How do
microRNAs regulate gene expression? Sci STKE 2007. re12007.
|
|
42
|
Ding G, Zhou L, Qian Y, Fu M, Chen J, Chen
J, Xiang J, Wu Z, Jiang G and Cao L: Pancreatic cancer-derived
exosomes transfer miRNAs to dendritic cells and inhibit RFXAP
expression via miR-212-3p. Oncotarget. 6:29877–29888. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang L, Huang J, Yang N, Greshock J,
Liang S, Hasegawa K, Giannakakis A, Poulos N, O'Brien-Jenkins A,
Katsaros D, et al: Integrative genomic analysis of
phosphatidylinositol 3′-kinase family identifies PIK3R3 as a
potential therapeutic target in epithelial ovarian cancer. Clin
Cancer Res. 13:5314–5321. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhou J, Chen GB, Tang YC, Sinha RA, Wu Y,
Yap CS, Wang G, Hu J, Xia X, Tan P, et al: Genetic and
bioinformatic analyses of the expression and function of PI3K
regulatory subunit PIK3R3 in an Asian patient gastric cancer
library. BMC Med Genomics. 5:342012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xu L, Wen Z, Zhou Y, Liu Z, Li Q, Fei G,
Luo J and Ren T: MicroRNA-7-regulated TLR9 signaling-enhanced
growth and metastatic potential of human lung cancer cells by
altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt
pathway. Mol Biol Cell. 24:42–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Klahan S, Wu MS, Hsi E, Huang CC, Hou MF
and Chang WC: Computational analysis of mRNA expression profiles
identifies the ITG family and PIK3R3 as crucial genes for
regulating triple negative breast cancer cell migration. Biomed Res
Int. 2014:5365912014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xia X, Cheng A, Akinmade D and Hamburger
AW: The N-terminal 24 amino acids of the p55 gamma regulatory
subunit of phosphoinositide 3-kinase binds Rb and induces cell
cycle arrest. Mol Cell Biol. 23:1717–1725. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Soroceanu L, Kharbanda S, Chen R, Soriano
RH, Aldape K, Misra A, Zha J, Forrest WF, Nigro JM, Modrusan Z, et
al: Identification of IGF2 signaling through
phosphoinositide-3-kinase regulatory subunit 3 as a
growth-promoting axis in glioblastoma. Proc Natl Acad Sci USA.
104:3466–3471. 2007; View Article : Google Scholar : PubMed/NCBI
|
